Graviti Pharmaceuticals Private Limited recalls Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceu
Recalled October 29, 2025 · FDA recall D-0037-2026 · Graviti Pharmaceuticals Private
Hazard
Failed Tablet/Capsule Specifications · FDA Class II
Units
46,512/30 count bottles
Sold at
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
Description
Failed Tablet/Capsule Specifications
Product
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
Manufacturer(s)
Graviti Pharmaceuticals Private Limited
Made in
India
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →